Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
American Cancer Society, National Institutes of Health, and Hope Foundation for Cancer Research.
American Cancer Society, National Institutes of Health, and Hope Foundation for Cancer Research.
In men with metastatic castration-resistant prostate cancer who had disease progression while receiving enzalutamide or abiraterone and who had alterations in genes with a role ...
h-index: Number of publications with at least h citations each.